Table 1.

Comparison of the median (p25-p75) percentages of immunolabeled nuclei (ki67, p53, and survivin) or relative cytoplasmic labeling intensity (p105) in histological subtypes of basal cell carcinomas and adjacent epidermis

	ki67^*	p53^*	Survivin^*	p105^**
Epidermis	7,5 (5,0-9,7)	7,2 (2,0-24,8)	2,3 (1,0-7,7)	124,7 (107,8-151,0)
Nodular	7,7 (5,3-11,7)^a	16,8 (3,3-57,7)^a	0,0 (0,0-0,0)^b	144,5 (113,0-165,0)
Superficial	9,3 (5,0-17,7)	63,3 (18,0-71,7)^a,b	0,8 (0,0-1,7)^b	132,2 (101,7-189,7)
Infiltrative	17,0 (12,7-21,3)^b	4,3 (0,0-15,0)	0,3 (0,0-1,0)^b	150,0 (122,7-159,7)
Recurrence	12,5 (9,0-18,3)^b	26,5 (4,0-62,7)^a,b	0,0 (0,0-3,0)^b	149,2 (127,0-157,3)

Percentage of immunolabelled nuclei in each histological field (hotspot)

^**

Relative intensity of cytoplasmic labeling.

p <0.05 compared to infiltrative; b p <0.05 relative to the epidermis